Covid-19 and people with neuromuscular disorders: World Muscle Society position and advice

Click here to read WMS advice on vaccines

Please note there is lots more general information available to WMS Members available on Guidelines.

The category of neuromuscular disease (NMD) covers a wide range of different diagnoses with widely varying levels of disability even in people with the same diagnosis. It is difficult, therefore to make specific recommendations that apply generally. The following are recommendations that apply to numerous neuromuscular disorders. These recommendations are designed primarily for patients, carers, general neurologists and non-specialist medical providers. They are also intended to inform neuromuscular specialists particularly regarding frequently asked questions and basic service requirements. In-depth reference links are provided.

Note: COVID-19 is a rapidly evolving field. The advice in this document is subject to regular revision. Please ensure that you are using the most up to date version of the document.

Disclaimer: WMS members have contributed to the translation of the original document into various languages. WMS assumes that all the translated content is true and accurate to the English original. 

Published on 23 April 2022.

Related

30 Jan 2026 WMS announces fee reductions for membership and Congress registration for 2026

29 Jan 2026 Highlights of the 18th Euro-Latin American Summer School of Myology (EVELAM) in San José, Costa Rica

06 Jan 2026 SciFam 2025

WMS Facebook Feed